Your browser doesn't support javascript.
loading
A Novel Tissue Atlas and Online Tool for the Interrogation of Small RNA Expression in Human Tissues and Biofluids.
Alsop, Eric; Meechoovet, Bessie; Kitchen, Robert; Sweeney, Thadryan; Beach, Thomas G; Serrano, Geidy E; Hutchins, Elizabeth; Ghiran, Ionita; Reiman, Rebecca; Syring, Michael; Hsieh, Michael; Courtright-Lim, Amanda; Valkov, Nedyalka; Whitsett, Timothy G; Rakela, Jorge; Pockros, Paul; Rozowsky, Joel; Gallego, Juan; Huentelman, Matthew J; Shah, Ravi; Nakaji, Peter; Kalani, M Yashar S; Laurent, Louise; Das, Saumya; Van Keuren-Jensen, Kendall.
Afiliación
  • Alsop E; Neurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, United States.
  • Meechoovet B; Neurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, United States.
  • Kitchen R; Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
  • Sweeney T; Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
  • Beach TG; Banner Sun Health Research Institute, Sun City, AZ, United States.
  • Serrano GE; Banner Sun Health Research Institute, Sun City, AZ, United States.
  • Hutchins E; Neurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, United States.
  • Ghiran I; Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States.
  • Reiman R; Neurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, United States.
  • Syring M; Neurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, United States.
  • Hsieh M; Neurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, United States.
  • Courtright-Lim A; Neurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, United States.
  • Valkov N; Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
  • Whitsett TG; Neurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, United States.
  • Rakela J; Mayo Clinic, Scottsdale, AZ, United States.
  • Pockros P; Division of Gastroenterology/Hepatology, Scripps Clinic, La Jolla, CA, United States.
  • Rozowsky J; Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, United States.
  • Gallego J; Institute for Behavioral Science, The Feinstein Institute for Medical Research, Manhasset, NY, United States.
  • Huentelman MJ; Division of Psychiatry Research, The Zucker Hillside Hospital, Glen Oaks, NY, United States.
  • Shah R; Department of Psychiatry, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, United States.
  • Nakaji P; Neurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, United States.
  • Kalani MYS; Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
  • Laurent L; Department of Neurosurgery, Banner Health, Phoenix, AZ, United States.
  • Das S; Department of Neurosurgery, St. John Medical Center, Tulsa, OK, United States.
  • Van Keuren-Jensen K; Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Diego, San Diego, CA, United States.
Front Cell Dev Biol ; 10: 804164, 2022.
Article en En | MEDLINE | ID: mdl-35317387
One promising goal for utilizing the molecular information circulating in biofluids is the discovery of clinically useful biomarkers. Extracellular RNAs (exRNAs) are one of the most diverse classes of molecular cargo, easily assayed by sequencing and with expressions that rapidly change in response to subject status. Despite diverse exRNA cargo, most evaluations from biofluids have focused on small RNA sequencing and analysis, specifically on microRNAs (miRNAs). Another goal of characterizing circulating molecular information, is to correlate expression to injuries associated with specific tissues of origin. Biomarker candidates are often described as being specific, enriched in a particular tissue or associated with a disease process. Likewise, miRNA data is often reported to be specific, enriched for a tissue, without rigorous testing to support the claim. Here we provide a tissue atlas of small RNAs from 30 different tissues and three different blood cell types. We analyzed the tissues for enrichment of small RNA sequences and assessed their expression in biofluids: plasma, cerebrospinal fluid, urine, and saliva. We employed published data sets representing physiological (resting vs. acute exercise) and pathologic states (early- vs. late-stage liver fibrosis, and differential subtypes of stroke) to determine differential tissue-enriched small RNAs. We also developed an online tool that provides information about exRNA sequences found in different biofluids and tissues. The data can be used to better understand the various types of small RNA sequences in different tissues as well as their potential release into biofluids, which should help in the validation or design of biomarker studies.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Cell Dev Biol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Cell Dev Biol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos